Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical neuropharmacology 2004-03, Vol.27 (2), p.58-62
Hauptverfasser:	Olanow, C Warren, Damier, Philippe, Goetz, Christopher G, Mueller, Thomas, Nutt, John, Rascol, Olivier, Serbanescu, Alexandru, Deckers, Frieda, Russ, Hermann
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antiparkinson Agents - adverse effects Antiparkinson Agents - therapeutic use Dose-Response Relationship, Drug Dyskinesia, Drug-Induced - drug therapy Dyskinesia, Drug-Induced - etiology Female Humans Levodopa - adverse effects Male Medical Records Organic Chemicals Parkinson Disease - drug therapy Parkinson Disease - physiopathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!